1,085 results on '"Ulcerative colitis -- Care and treatment"'
Search Results
2. Medical finding: Vitamin D key to severity of inflammatory bowel disease
3. AbbVie advances in bowel disease treatment 'gold rush'
4. Eli Lilly to buy intestinal disease drug developer for $3.2 billion dollars
5. Xuchang Vocational Technical College Researchers Publish New Studies and Findings in the Area of Ulcerative Colitis (Improving Effect of Ligustilide on Dextran Sodium Sulfate-induced Ulcerative Colitis)
6. Southwest University Researcher Illuminates Research in Ulcerative Colitis (Protective Effects of Four Structurally Distinct Sanshools Ameliorate Dextran Sodium Sulfate-Induced Ulcerative Colitis by Restoring Intestinal Barrier Function and ...)
7. Researcher at Juntendo University Has Published New Data on Ulcerative Colitis (P1225 The interplay of donor-derived gut microbiota correlates with the efficacy of combination therapy of fecal microbiota transplantation with antibiotics for ...)
8. Studies from Southwest University in the Area of Ulcerative Colitis Reported (Transient Mild Photothermia Improves Therapeutic Performance of Oral Nanomedicines With Enhanced Accumulation In the Colitis Mucosa)
9. New Findings in Ulcerative Colitis Described from Changchun University of Traditional Chinese Medicine (Fufangxiaopi Formula Alleviates Dss-induced Colitis In Mice By Inhibiting Inflammatory Reaction, Protecting Intestinal Barrier and ...)
10. Findings from Western General Hospital in the Area of Ulcerative Colitis Described (Real-world Cohort Study On the Effectiveness and Safety of Filgotinib Use In Ulcerative Colitis)
11. Studies from Tianjin University of Traditional Chinese Medicine Yield New Data on Ulcerative Colitis (Combination Of Coptis Chinensis Polysaccharides and Berberine Ameliorates Ulcerative Colitis By Regulating Gut Mic
12. AbbVie Announces European Commission Approval of SKYRIZI(r) (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
13. AbbVie Announces European Commission Approval of SKYRIZI (risankizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
14. Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
15. Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study
16. Scientists make huge breakthrough as major cause of inflammatory bowel disease found; More than half a million people living with IBD in the UK
17. Inflammatory bowel disease patients demand access to treatments
18. An uncontrolled disease in almost half of the people who suffer from it
19. Harbin Normal University Researcher Provides Details of New Studies and Findings in the Area of Ulcerative Colitis (Trans-Anethole Alleviates DSS-Induced Ulcerative Colitis by Remodeling the Intestinal Flora to Regulate Immunity and Bile Acid ...)
20. Data from Tufts Medical Center Broaden Understanding of Ulcerative Colitis (Specific bacterial co-abundance groups are associated with inflammatory status in patients with ulcerative colitis)
21. Data on Inflammatory Bowel Disease Detailed by a Researcher at Sao Paulo State University (UNESP) (Risks and benefits of anti-TNF therapy for ulcerative colitis in a patient with autoimmune hepatitis-related cirrhosis: Case report)
22. Bukhara State Medical Institute Researchers Add New Study Findings to Research in Ulcerative Colitis (Assessment of the severity of ulcerative colitis: An effective pathway from invasive to non-invasive diagnosis)
23. Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis: a distinct form of colitis
24. A Multi-Center Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin Rich Extract (ACRE) in Patients with Ulcerative Colitis
25. Reports Outline Ulcerative Colitis Research from Shiraz University of Medical Sciences (Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ...)
26. Recent Findings from AbbVie Has Provided New Information about Ulcerative Colitis (Serene Er Analysis Part 2 Serene-uc: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately To Severely ...)
27. Reports Outline Ulcerative Colitis Study Findings from Ain Shams University (Serum Resistin Level as a Novel Marker of Disease Activity in Patients with Ulcerative Colitis)
28. Researcher at Western University Details Research in Ulcerative Colitis (The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program)
29. Use the stool! Fecal microbiota transplants help kids with diarrheal infection
30. AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
31. Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S
32. Teva and Alvotech Announce SIMLANDI(R) (adalimumab-ryvk) Injection Now Available in the U.S
33. Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' Stool
34. Biora Therapeutics submits IND application to US FDA for BT-600 programme to treat moderate to severe ulcerative colitis
35. Researchers at Beijing University of Chinese Medicine Publish New Study Findings on Ulcerative Colitis (Protective effect of carbon dots derived from scrambled Coptidis Rhizoma against ulcerative colitis in mice)
36. New Findings from Huazhong University of Science and Technology Update Understanding of Ulcerative Colitis (Quercetin Serves As the Major Component of Xiang-lian Pill To Ameliorate Ulcerative Colitis Via Tipping the Balance of Stat1/ppar Gamma ...)
37. Reports from University of Padua Add New Data to Findings in Ulcerative Colitis (Efficacy and Safety of Oral Beclomethasone Dipropionate and Budesonide Mmx Versus 5-aminosalicylates or Placebo In Ulcerative Colitis: a Systematic Review and ...)
38. Findings from Heilongjiang Bayi Agricultural University Update Understanding of Ulcerative Colitis (Network Pharmacology Based Research Into the Effect and Potential Mechanism of Portulaca Oleracea L. Polysaccharide Against Ulcerative Colitis)
39. OSE Immunotherapeutics gets DSMB recommendation to continue phase 2 trial of Lusvertikimab in ulcerative colitis
40. Studies from University of Oxford in the Area of Ulcerative Colitis Described [Development of the Escalation of Therapy or Intervention (ETI) calculator for patients with ulcerative colitis using ePROMS]
41. New Marijuana Laws Findings from University of Western Ontario Described (Cannabis use in patients with inflammatory bowel disease following legalization of Cannabis in Canada)
42. New Data from Medical University of Plovdiv Illuminate Research in Artificial Intelligence (The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis)
43. Study Data from Kitasato University Kitasato Institute Hospital Update Understanding of Ulcerative Colitis (Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ...)
44. Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update
45. United Kingdom : Etrasimod approved to treat patients over the age of 16 with ulcerative colitis
46. New Research Study for Patients With Ulcerative Colitis Now Available in Ogden, Utah
47. Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
48. European Commission Approves Pfizer's VELSIPITY(r) For Patients with Moderately to Severely Active Ulcerative Colitis
49. European Commission approves Pfizer's VELSIPITY for patients with moderately to severely active ulcerative colitis
50. European Commission Approves Pfizer's VELSIPITY[R] for Patients with Moderately to Severely Active Ulcerative Colitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.